1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co. Ltd.
  6. Company
    1099   CNE100000FN7

SINOPHARM GROUP CO. LTD.

(1099)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-06-24 am EDT
19.36 HKD   +0.83%
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, Payable No Later Than 23 August 2022
CI
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
06/17Sinopharm Group Co. Ltd. Announces Executive Changes
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sinopharm Group Co. Ltd.
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Number of employees : 113 234 people.
Sales per Business
20202021Delta
Pharmaceutical Distribution380 495.0074.2%454 485.0072.4% +19.45%
Medical Devices98 860.8019.3%129 455.0020.6% +30.95%
Retail Pharmacy26 678.905.2%34 438.005.5% +29.08%
Other6 835.261.3%9 598.911.5% +40.43%
HKD in Million
Sales per region
20202021Delta
China512 870.00100%627 977.00100% +22.44%
HKD in Million
Managers
Name Title Age Since
Yong Liu President & Executive Director 52 2017
Xiao Juan Li Chief Financial Officer 45 2021
Yi Jian Wu Secretary 51 2021
Jun Lu Vice President 63 2012
Guang Fu Li Vice President 63 2011
Zhong Xi Cai Vice President 55 2010
Shuang Jun Xu Non-Executive Vice President 52 2013
Xiu Chang Jiang Vice President 57 2021
Members of the board
Name Title Age Since
Fang Yao Chairman-Supervisory Board 52 2011
Qing Ming Yu Chairman 57 2021
Wu Ping Tao Member-Supervisory Board 66 2015
Zheng Dong Liu Independent Supervisor 51 2020
Fu Min Zhuo Independent Non-Executive Director 69 2016
Fang Ruo Chen Independent Non-Executive Director 56 2019
Tak Lung Wu Independent Non-Executive Director 56 2020
Wei Feng Yu, Dr. Independent Non-Executive Director 58 2020
Yi Fang Wu Independent Supervisor 52 2020
Pei Yu Li, Dr. Independent Non-Executive Director 58 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,341,810,740 1,341,565,931 100.0% 0 0.0% 43.0%
Stock B 1 1,778,845,451 0 0.0% 0 0.0%
Shareholders
NameEquities%
Fidelity Management & Research Co. LLC 99,047,285 7.38%
Thornburg Investment Management, Inc. 64,013,100 4.77%
Lazard Asset Management LLC 40,450,693 3.01%
The Vanguard Group, Inc. 40,244,125 3.00%
Norges Bank Investment Management 30,143,905 2.25%
Hermes Investment Management Ltd. 29,895,200 2.23%
BlackRock Fund Advisors 29,822,400 2.22%
Dimensional Fund Advisors LP 28,761,887 2.14%
Swedbank Robur Fonder AB 23,549,745 1.76%
Black Creek Investment Management, Inc. 23,060,391 1.72%
Holdings
NameEquities%Valuation
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. (000028) 234,494,221 63.8% 1,014,171,091 USD
CHINA NATIONAL MEDICINES CORPORATION LTD. (600511) 211,685,171 38.3% 890,402,867 USD
CHINA NATIONAL MEDICINES CORPORATION LTD. 201,156,574 100.0% 846,116,851 USD
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. (600420) 19,068,440 1.86% 26,009,924 USD
SHENZHEN ACCORD PHARMA DOM SH 5,505,770 99.9% 23,812,070 USD
Company contact information
Sinopharm Group Co., Ltd.
Sinopharm Plaza
No. 1001, Zhongshan West Road
Changning District
Shanghai 200051

Phone : +86.21.6321.1750
Fax : +86.21.6321.2722
Web : http://www.sinopharmholding.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sinopharm Group Co. Ltd.